Bonus BioGroup Ltd. (BONS.TA)
ILA 9.1
(0.0%)
ILA 9.1
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -28.13 Million ILS | -3.73% |
| 2022 | -35.6 Million ILS | 59.54% |
| 2021 | -67.05 Million ILS | -264.56% |
| 2020 | -18.39 Million ILS | 8.16% |
| 2019 | -20.02 Million ILS | -10.2% |
| 2018 | -18.17 Million ILS | 8.98% |
| 2017 | -19.96 Million ILS | -29.37% |
| 2016 | -15.43 Million ILS | -19.56% |
| 2015 | -12.9 Million ILS | -20.18% |
| 2014 | -10.74 Million ILS | -12.75% |
| 2013 | -9.52 Million ILS | 47.12% |
| 2012 | -18.01 Million ILS | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -6.15 Million ILS | 12.46% |
| 2024 Q1 | -7.02 Million ILS | -6.04% |
| 2023 Q4 | -6.62 Million ILS | -14.2% |
| 2023 Q3 | -5.8 Million ILS | -1.06% |
| 2023 FY | - ILS | -3.73% |
| 2023 Q1 | -6.71 Million ILS | 60.43% |
| 2023 Q2 | -5.74 Million ILS | 14.56% |
| 2022 Q3 | -7.27 Million ILS | -92.97% |
| 2022 Q2 | -3.77 Million ILS | 42.28% |
| 2022 FY | - ILS | 59.54% |
| 2022 Q1 | -6.53 Million ILS | 80.75% |
| 2022 Q4 | -16.97 Million ILS | -133.35% |
| 2021 Q1 | -35.27 Million ILS | -344.13% |
| 2021 Q3 | -9.87 Million ILS | -24.87% |
| 2021 Q4 | -33.93 Million ILS | -243.75% |
| 2021 FY | - ILS | -264.56% |
| 2021 Q2 | -7.9 Million ILS | 77.59% |
| 2020 Q2 | -3.89 Million ILS | 7.82% |
| 2020 FY | - ILS | 8.16% |
| 2020 Q4 | -7.94 Million ILS | -187.27% |
| 2020 Q3 | -2.76 Million ILS | 28.94% |
| 2020 Q1 | -4.22 Million ILS | 18.47% |
| 2019 Q1 | -7.08 Million ILS | -38.59% |
| 2019 Q2 | -3.94 Million ILS | 44.32% |
| 2019 Q3 | -4.29 Million ILS | -8.74% |
| 2019 Q4 | -5.17 Million ILS | -20.62% |
| 2019 FY | - ILS | -10.2% |
| 2018 Q4 | -5.11 Million ILS | -23.02% |
| 2018 Q3 | -4.15 Million ILS | -6.18% |
| 2018 Q2 | -3.91 Million ILS | 21.44% |
| 2018 Q1 | -4.98 Million ILS | -37.14% |
| 2018 FY | - ILS | 8.98% |
| 2017 Q2 | -3.54 Million ILS | -1.99% |
| 2017 Q1 | -3.47 Million ILS | -7.22% |
| 2017 Q3 | -9.31 Million ILS | -162.65% |
| 2017 FY | - ILS | -29.37% |
| 2017 Q4 | -3.63 Million ILS | 60.96% |
| 2016 Q3 | -6.19 Million ILS | -102.25% |
| 2016 Q4 | -3.24 Million ILS | 47.65% |
| 2016 Q1 | -3.05 Million ILS | 28.46% |
| 2016 Q2 | -3.06 Million ILS | -0.2% |
| 2016 FY | - ILS | -19.56% |
| 2015 FY | - ILS | -20.18% |
| 2015 Q2 | -2.8 Million ILS | -13.3% |
| 2015 Q1 | -2.47 Million ILS | 10.56% |
| 2015 Q4 | -4.27 Million ILS | -27.14% |
| 2015 Q3 | -3.36 Million ILS | -19.87% |
| 2014 Q1 | -3.06 Million ILS | 2.51% |
| 2014 Q4 | -2.76 Million ILS | -34.34% |
| 2014 Q3 | -2.05 Million ILS | 27.81% |
| 2014 Q2 | -2.85 Million ILS | 6.92% |
| 2014 FY | - ILS | -12.75% |
| 2013 FY | - ILS | 47.12% |
| 2013 Q1 | -2.12 Million ILS | 0.0% |
| 2013 Q4 | -3.14 Million ILS | -31.01% |
| 2013 Q3 | -2.39 Million ILS | -28.77% |
| 2013 Q2 | -1.86 Million ILS | 12.16% |
| 2012 FY | - ILS | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Matricelf Ltd | -11.51 Million ILA | -144.423% |